Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.1.069

Polymorphic Variation in Glutathione-S-transferase Genes and Risk of Chronic Myeloid Leukaemia in the Kashmiri Population  

Bhat, Gulzar (Department of Biochemistry, University of Kashmir)
Bhat, Ashaqullah (Department of Biochemistry, University of Kashmir)
Wani, Aadil (Department of Biochemistry, University of Kashmir)
Sadiq, Nida (Department of Biochemistry, University of Kashmir)
Jeelani, Samoon (Department of Clinical Hematology, SKIMS)
Kaur, Rajinder (Department of Human Biology, Punjabi University)
Masood, Akbar (Department of Biochemistry, University of Kashmir)
Ganai, Bashir (Department of Biochemistry, University of Kashmir)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.1, 2012 , pp. 69-73 More about this Journal
Abstract
Cancer is a complex disease and the genetic susceptibility to it could be an outcome of the inherited difference in the capacity of xenobiotic metabolizing enzymes. Glutathione-S-transferases (GSTs) are phase II metabolizing enzymes whose various genotypes have been associated with increased risk of different types of cancer. Null mutations caused by the deletion of the entire gene result in the absence of the enzymatic activity and increase in the risk of developing cancer including chronic myeloid leukaemia (CML). In the present case-control study we evaluated the effect of null mutations in GSTM1 and GSTT1 genes on the risk of developing CML. The study included 75 CML patients (43 males and 32 females; age (mean ${\pm}$ S.D) $42.3{\pm}13.4$ years) and unrelated non-malignant controls (76 male and 48 females; age (mean ${\pm}$ S.D) $41.5{\pm}12.9$). The distribution of GSTM1 and GSTT1 genotypes in CML patients and controls was assessed by multiplex-PCR method. Logistic regression was used to assess the relationship between GSTM1 and GSTT1 genotypes and risk of CML. Chi-square test was used to evaluate the trend in modulating the risk to CML by one or more potential high risk genotype. Although GSTM1 null genotype frequency was higher in CML patients (41%) than in the controls (35%), it did not reached a statistical significance (OD = 1.32, 95% CI: 0.73-2.40; P value = 0.4295). The frequency of GSTT1 null genotypes was higher in the CML patients (36%) than in the controls (21%) and the difference was found to be statistically significant (OD = 2.12, 95% CI: 1.12-4.02; P value = 0.0308). This suggests that the presence of GSTT1genotype may have protective role against the CML. We found a statistically significant (OD = 3.09, 95% CI: 1.122-8.528; P value = 0.0472) interaction between the GSTM1 and GSTT1 null genotypes and thus individuals carrying null genotypes of both GSTM1 and GSTT1 genes are at elevated risk of CML.
Keywords
Glutathione S transferase; CML; GSTM1; GSTT1; genetic polymorphisms;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rollinson S, Roddam P, Kane E, et al (2000). Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis, 21, 43-7.   DOI
2 Redaelli A, Bell C, Casagrande J, et al (2004). Clinical and epidemiologic burden of chronic myelogenous leukemia. Expert Rev Anticancer Ther, 4, 85-96.   DOI
3 Rowley JD. (1973). Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-3.   DOI
4 Roy B, Majumder PP, Dey B, et al (2001). Ethnic differences in distributions of GSTM1 and GSTT1 homozygous "null" genotypes in India. Hum Biol, 73, 443-50.   DOI
5 Sambrook J, Rusell (2001).Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
6 Tan W, Song N, Wang GQ, et al (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomarkers Prev, 9, 551-6.
7 Weber WW (1999). Populations and genetic polymorphisms. Mol Diagn, 4, 299-307.   DOI
8 Xu X, Wiencke JK, Niu T, et al (1998). Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am J Ind Med, 33, 157-63.   DOI
9 Hallier E, Langhof T, Dannappel D, et al (1993). Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol, 67, 173-8.   DOI
10 Hishida A, Terakura S, Emi N, et al (2005) .GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev, 6, 251-5.
11 Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993). The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol, 14, 77-87.   DOI
12 Lourenco GJ, Ortega MM, Nascimento H, et al (2005). Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur J Haematol, 75, 530-1.   DOI
13 Meggyesi N, Kozma A, Halm G, et al (2011). Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients. Acta Haematologica, 127, 34-42.   DOI
14 McLellan RA, Oscarson M, Alexandrie AK, et al (1997). Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol , 52, 958-65.   DOI
15 Bajpai P, Tripathi AK, Agrawal D (2007). Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk. Res, 31, 1359-63.   DOI
16 Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B (2010). Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer, 62, 734-42.   DOI
17 Mondal BC, Paria N, Majumdar S, et al (2005). Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev, 14, 281-4.   DOI
18 Quinones L, Lucas D, Godoy J, et al (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett, 174, 35-44.   DOI
19 Cai L, Yu SZ, Zhang ZF (2001). Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol, 7, 5060-9.
20 Canalle R, Burim RV, Tone LG, Takahashi CS (2004). Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen, 43, 100-9.   DOI
21 Chen H C, Hu W X, Liu Q X, et al (2008). Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev, 17, 251-8.   DOI
22 Deininger MW, Goldman JM, Melo JV (2000). The molecular biology of chronic myeloid leukemia. Blood, 96, 3343-56.
23 Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM(1999). The biology of chronic myeloid leukemia. N Engl J Med, 341, 164-72.   DOI
24 Garte S, Taioli E, Crosti F, et al (2000). Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia. Leuk Res, 24, 971-4.   DOI
25 Autrup H (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res, 464, 65-76.   DOI
26 Ghanei M, Vosoghi AA (2002). An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect, 110, 519-21.   DOI
27 Hishida A, Terakura S, Emi N, et al 2005 . GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev , 6, 251-5.
28 Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.   DOI
29 Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E (2004). CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet. Cytogenet, 154, 81-5.   DOI
30 Arand M, Mühlbauer R, Hengstler J, et al (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem, 236, 184-6.   DOI